Dietary Glycemic Index, Glycemic Load, and Risk of Lung Cancer: A Population-Based Cohort Study
“CONCLUSIONS These findings show that high dietary GI is associated with an increased risk of lung cancer, NSCLC, and SCLC, whereas GL is inversely associated with the risk of lung cancer and NSCLC.”
Missing cancer gene may boost response to immunotherapy
“For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there’s new hope. In a new study published in Cell Reports, Mayo Clinic researchers have found several previously unknown genetic and cellular processes that occur in lung adenocarcinoma tumors that respond well to immunotherapy.”
Understanding Minimally Invasive Lung Cancer Care Advancements
“Dr. Daniel J. Boffa, professor and division chief of Thoracic Surgery at Yale School of Medicine in New Haven, Connecticut, sat down with CURE to discuss the evolving landscape of lung cancer treatment. In the interview, he highlights major advancements that are transforming patient care, including the role of minimally invasive surgical techniques that preserve lung function and new systemic therapies such as immunotherapy and targeted therapy. These innovations are enabling more precise treatments and personalized approaches to improve outcomes while minimizing side effects for patients with lung cancer.”
